Viewing Study NCT00288002

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2025-12-26 @ 3:02 AM
Study NCT ID: NCT00288002
Status: COMPLETED
Last Update Posted: 2013-08-26
First Post: 2006-02-06
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
Sponsor: GBG Forschungs GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None inflammatory breast cancer View
None stage II breast cancer View
None stage IIIA breast cancer View
None stage IIIB breast cancer View
None stage IIIC breast cancer View
None stage IA breast cancer View
None stage IB breast cancer View
None estrogen receptor-negative breast cancer View
None estrogen receptor-positive breast cancer View
None HER2-negative breast cancer View
None HER2-positive breast cancer View